'Game-changing鈥� Alzheimer鈥檚 drug lecenemab rejected by EU
29 July 2024
鈥淭his conservative approach means that patients and doctors eager to explore a proven effective drug are now denied access," explains Professor Bart De Strooper (UCL Queen Square Institute of Neurology).
Close
